Bernstein analyst Oswald Clint upgrades Equinor (NYSE:EQNR) from Market Perform to Outperform.
Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.